The Missing Piece in the Mental Health Puzzle

Why revolutionizing the field requires quantifiable data supported by investors and healthcare leaders

  • A significant barrier to accurate diagnosis and effective treatment of depression and anxiety is over-reliance on subjective behavioral data
  • Improving outcomes in the mental health space requires companies to push beyond established approaches and focus on objective, quantifiable metrics
  • Recent data-driven innovations in mental health measurement and monitoring, in particular physical and digital biomarkers, hold exceptional promise and offer a wealth of opportunities for patients, healthcare systems, and investors
  • Biomarkers can be physical or digital, and tradeoffs include quality of data vs. barriers to collection
  • New biomarkers will need patient, practitioner and payer buy-in to eventually change outcomes at scale

--

--

Able Partners is an investment fund focused on supporting visionary, early stage brands in positive living.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Able Partners

Able Partners is an investment fund focused on supporting visionary, early stage brands in positive living.